Physician

Abdul S. Khan, MD

According to 2025 Medicare claims, Abdul Khan, MD (NPI: 1528028578) practices neurology in the Albany-Schenectady-Troy, NY market, with the plurality of this provider's patient population coming from Rensselaer, NY. This provider's primary affiliated billing organization is ST. PETER'S HEALTH PARTNERS MEDICAL ASSOCIATES, P.C. (NPI: 1750626834; TIN: 461177336) and primary practice location at 12065-3890. Khan is affiliated with the Bassett Accountable Care Partners, LLC (ACO ID: A2612) and Trinity Health Integrated Care (ACO ID: A3454), participating under the MSSP model.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 478 traditional Medicare patients, billed 702 HCPCS/CPT codes, and received $71,837 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 3,307 prescription claims across 661 beneficiaries totaling $702,642 in drug costs, led by Nurtec Odt (Rimegepant Sulfate). 2023 DME data shows 33 claims. Open Payments data shows 179 records totaling $2,521. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $288,173 to $702,642. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,174 to $2,748.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	432	828	$73,245
2016	429	841	$78,844
2017	395	744	$68,533
2018	399	2,580	$75,839
2019	435	724	$66,777
2020	410	875	$68,210
2021	360	1,030	$66,985
2022	412	644	$72,593
2023	450	1,682	$81,398
2024	478	702	$71,837

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	288	1,803	$288,173
2016	300	1,997	$335,299
2017	348	2,413	$430,631
2018	369	2,849	$364,501
2019	412	2,932	$419,075
2020	437	3,023	$573,650
2021	484	3,070	$563,554
2022	499	3,083	$734,441
2023	542	2,894	$722,193
2024	661	3,307	$702,642

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$776
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	26	$1,122
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	33	$2,534
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	34	35	$127
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	89	101	$123
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	156	156	$113
95816	Measurement of brain wave activity (eeg), awake and drowsy	37	38	$110
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	237	282	$85

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nurtec Odt	Rimegepant Sulfate	69	1,775	$107,077
Octagam	Immun Globg(Igg)/Malt/Iga Ov50	23	644	$77,158
Copaxone	Glatiramer Acetate	11	308	$62,741
Ubrelvy	Ubrogepant	53	1,406	$59,280
Emgality Pen	Galcanezumab-Gnlm	57	2,296	$58,601

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	179	$2,521	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdul S. Khan, MD?

Tedicare shows public-source Medicare data for Abdul S. Khan, MD (NPI 1528028578), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdul S. Khan, MD have ACO affiliation data?

Abdul S. Khan, MD is shown with ACO affiliation data for Bassett Accountable Care Partners, LLC (MSSP, ACO ID A2612) and Trinity Health Integrated Care (MSSP, ACO ID A3454).

What billing organization is linked to Abdul S. Khan, MD?

Abdul S. Khan, MD is linked to ST. PETER'S HEALTH PARTNERS MEDICAL ASSOCIATES, P.C. (billing NPI 1750626834) in the available physician profile data.

Does Abdul S. Khan, MD have Open Payments data?

Abdul S. Khan, MD has 179 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.